Last updated on July 2017

Study of VIS410 in Subjects With Uncomplicated Influenza A


Brief description of study

This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the safety and tolerability of VIS410 in subjects with uncomplicated influenza.

Detailed Study Description

Subjects will be admitted to an infusion unit for drug administration and observation following infusion. The study is designed to compare an infusion of a single high or low IV dose of VIS410 against placebo. Subjects will be followed for 100 (±7 days).

Clinical Study Identifier: NCT02989194

Contact Investigators or Research Sites near you

Start Over

Visterra Inc

Huntsville, AL United States
  Connect »

Visterra Inc

Coral Gables, FL United States
  Connect »

Visterra Inc

Homestead, FL United States
  Connect »

Visterra Inc

Miami, FL United States
  Connect »

Visterra Inc

Orlando, FL United States
  Connect »

Visterra Inc

Eunice, LA United States
  Connect »

Visterra Inc

New Orleans, LA United States
  Connect »

Visterra Inc

Shelby, NC United States
  Connect »

Visterra Inc

Houston, TX United States
  Connect »

Visterra Inc

McAllen, TX United States
  Connect »

Visterra Inc

Asenovgrad, Bulgaria
  Connect »

Visterra Inc

Sofia, Bulgaria
  Connect »

Visterra Inc

Velingrad, Bulgaria
  Connect »

Visterra Inc

Tallinn, Estonia
  Connect »

Visterra Inc

Daugavpils, Latvia
  Connect »

Visterra Inc

Liepaja, Latvia
  Connect »

Visterra Inc

Rezekne, Latvia
  Connect »

Visterra Inc

Valmiera, Latvia
  Connect »

Visterra Inc

Ventspils, Latvia
  Connect »

Visterra Inc

Kragujevac, Serbia
  Connect »

Visterra Inc

Novi Sad, Serbia
  Connect »

Visterra

Welkom, South Africa
  Connect »

Visterra

Benoni, South Africa
  Connect »

Visterra

Centurion, South Africa
  Connect »

Visterra

Johannesburg, South Africa
  Connect »

Visterra

Kempton Park, South Africa
  Connect »

Visterra

Pretoria West, South Africa
  Connect »

Visterra

Pretoria, South Africa
  Connect »

Visterra

Soshanguve, South Africa
  Connect »

Visterra

Soweto, South Africa
  Connect »

Visterra

Durban, South Africa
  Connect »

Visterra

Thabazimbi, South Africa
  Connect »

Visterra

Middelburg, South Africa
  Connect »

Visterra

Witbank, South Africa
  Connect »

Visterra

Cape Town, South Africa
  Connect »

Visterra

Worcester, South Africa
  Connect »

Visterra Inc

Kharkiv, Ukraine
  Connect »

Visterra Inc

Vinnytsya, Ukraine
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.